VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile

✉ Email this page to a colleague

When do Vaprisol In 5% Dextrose In Plastic Container patents expire, and when can generic versions of Vaprisol In 5% Dextrose In Plastic Container launch?

Vaprisol In 5% Dextrose In Plastic Container is a drug marketed by Cumberland and is included in one NDA.

The generic ingredient in VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is conivaptan hydrochloride. Additional details are available on the conivaptan hydrochloride profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER?
What are the global sales for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER?
What is Average Wholesale Price for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER?

Summary for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	16
DailyMed Link:	VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER at DailyMed

Drug patent expirations by year for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

Recent Clinical Trials for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Jesse Corry	Phase 1
University of Florida	Phase 2
Finn Gustafsson	Phase 4

See all VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cumberland	VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER	conivaptan hydrochloride	INJECTABLE;INTRAVENOUS	021697-002	Oct 8, 2008		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cumberland	VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER	conivaptan hydrochloride	INJECTABLE;INTRAVENOUS	021697-002	Oct 8, 2008	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

See the table below for patents covering VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Ukraine	64690	A CONDENSED BENZADEPINE DERIVATIVE, AN INTERMEDIATE COMPOUND FOR PREPARING THEREOF AND A PHARMACEUTICAL COMPOSITION	⤷ Sign Up
Finland	960260		⤷ Sign Up
Austria	277003		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

Recent Clinical Trials for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER

Make Better Decisions: Try a trial or see plans & pricing